MARKET INSIGHTS

ZTOX Insights

AI-assisted articles on quarterly results, exchange filings, and earnings calls — tied to the companies you follow.

32 articles published

All Market Updates (8967) Corporate announcement (8258) Financial Results (3178) Earnings conference call (344) Chartink scans (124) BSE filings (119) NSE filings (72) TECHNOCRAFT INDUSTRIES (INDIA) (52) Live gainers (47) Network People Services Technologies (41)

Results for “CONCOR” · in Corporate announcement — Clear filters

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech Receives USFDA Approval for Mycophenolate Mofetil Suspension

Concord Biotech has secured USFDA approval for its Mycophenolate Mofetil for Oral Suspension USP, marking a key regulatory milestone for the company.

Read article

CEWATER

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Enviro Systems (CEWATER): Bagging/Receiving of orders/contracts

Bagging/Receiving of orders/contracts Receipt of Order by Rochem Separation Systems (India) Private Limited Receipt of Order by Rochem Separation Systems (India) Private Limited

Read article

CEWATER

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Enviro Systems (CEWATER): Bagging/Receiving of orders/contracts

Bagging/Receiving of orders/contracts Receipt of Order by Rochem Separation Systems (India) Private Limited Receipt of Order by Rochem Separation Systems (India) Private Limited

Read article

CEWATER

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Enviro Systems (CEWATER): Company Update

Company Update Receipt of Order by the Rochem Seperation Systems (India) Private Limited, Material Subsidiary of the Company of Rs. 16 Crores Receipt of Order by the Rochem Seperation Systems (India) Private Limited, Material Subsidiary of the Company of Rs. 16 Crores

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Updates

Updates Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'. Concord Biotech Limited has informed the Exchange regarding Abbreviated New Drug Application (ANDA) Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL'.

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Updates

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Company Update

Company Update We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Company Update

Read article

CNCRD

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Control Systems (CNCRD): Company Update

Company Update Press Release of order Press Release of order

Read article

CNCRD

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Control Systems (CNCRD): Company Update

Company Update Press Release of order Press Release of order

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Investor Presentation

Investor Presentation Concord Biotech Limited has informed the Exchange about Investor Presentation Concord Biotech Limited has informed the Exchange about Investor Presentation

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement

Concord Biotech (CONCORDBIO): Outcome of Board Meeting

Outcome of Board Meeting Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Concord Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Read article

CONCORDBIO

Jun 4, 2026 1 min read

Market Updates Corporate announcement